FRANCE-HEALTH-WOMEN-CONTRACEPTION : Foto di attualità

FRANCE-HEALTH-WOMEN-CONTRACEPTION

Attestazione: 
MARTIN BUREAU / Staff
Dominique Maraninchi (R), head of France's regulator the National Agency for the Safety of Drugs and Health Products (ANSM) speaks during a press conference on acne pill Diane 35, on January 30, 2013 in Paris. In the latest health scare to erupt in France, a drug watchdog on Wednesday announced it was suspending sales of an acne pill also used as a contraceptive after four women died and more than 100 others fell ill with blood clots. The National Agency for the Safety of Drugs and Health Products (ANSM) said it was suspending sales of a hormonal treatment called Diane-35, which is prescribed to 315,000 women in France. the product, made by the German firm Bayer, is authorised for treating acne in young women, but doctors have been prescribing it as a contraceptive because it stops ovulation, he said. AFP PHOTO MARTIN BUREAU (Photo credit should read MARTIN BUREAU/AFP/Getty Images)
Didascalia:
Dominique Maraninchi (R), head of France's regulator the National Agency for the Safety of Drugs and Health Products (ANSM) speaks during a press conference on acne pill Diane 35, on January 30, 2013 in Paris. In the latest health scare to erupt in France, a drug watchdog on Wednesday announced it was suspending sales of an acne pill also used as a contraceptive after four women died and more than 100 others fell ill with blood clots. The National Agency for the Safety of Drugs and Health Products (ANSM) said it was suspending sales of a hormonal treatment called Diane-35, which is prescribed to 315,000 women in France. the product, made by the German firm Bayer, is authorised for treating acne in young women, but doctors have been prescribing it as a contraceptive because it stops ovulation, he said. AFP PHOTO MARTIN BUREAU (Photo credit should read MARTIN BUREAU/AFP/Getty Images)
Calcola prezzoVisualizza carrello
Data di creazione:
30 gennaio 2013
N. Editorial:
160367840
Info sulla liberatoria:
Senza liberatoria.Ulteriori informazioni
Restrizioni:
Contatta l'ufficio locale per informazioni su qualsiasi tipo di uso commerciale o promozionale. Diritti editoriali illimitati per Regno Unito, Stati Uniti, Irlanda, Italia, Spagna, Canada (escluso Quebec). Diritti editoriali limitati in altri Paesi. Contatta l'ufficio locale.
Tipo di licenza:
Rights-managedLe licenze dei prodotti rights-managed impongono specifiche restrizioni sull'utilizzo, tra cui quelle relative a dimensioni, posizionamento, durata d'uso e distribuzione geografica. Ti verrà chiesto di inviare informazioni sull'utilizzo previsto del prodotto, che saranno utilizzate per determinare l'ambito di uso consentito per la concessione dei diritti.
Collezione:
AFP
Attestazione:
AFP/Getty Images
Max. dimensione file:
4.928 x 3.280 px (173,85 x 115,71 cm) - 72 dpi - 4 MB
Fonte:
AFP
Codice a barre:
AFP
Nome oggetto:
Par7459322

Parole chiave

Immagine protetta da copyright. Getty Images si riserva il diritto di adire le vie legali contro i fruitori non autorizzati di questa immagine o clip e chiedere il risarcimento dei danni per le violazioni del copyright. La disponibilità di questa immagine non può essere garantita fino al momento dell'acquisto.
Dominique Maraninchi head of France's regulator the National Agency... Foto di attualità 160367840Composizione orizzontale,Conferenza stampa,Diane,Francia,Parigi,Parlare,Pillola,Sanità e medicina,TestaPhotographer Collection: AFP 2013 AFPDominique Maraninchi (R), head of France's regulator the National Agency for the Safety of Drugs and Health Products (ANSM) speaks during a press conference on acne pill Diane 35, on January 30, 2013 in Paris. In the latest health scare to erupt in France, a drug watchdog on Wednesday announced it was suspending sales of an acne pill also used as a contraceptive after four women died and more than 100 others fell ill with blood clots. The National Agency for the Safety of Drugs and Health Products (ANSM) said it was suspending sales of a hormonal treatment called Diane-35, which is prescribed to 315,000 women in France. the product, made by the German firm Bayer, is authorised for treating acne in young women, but doctors have been prescribing it as a contraceptive because it stops ovulation, he said. AFP PHOTO MARTIN BUREAU (Photo credit should read MARTIN BUREAU/AFP/Getty Images)